BlackRock Health Sciences Trust (BME) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the BlackRock Health Sciences Trust stock forecast from 0 analysts, the average analyst target price for BlackRock Health Sciences Trust is not available over the next 12 months. BlackRock Health Sciences Trust’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BlackRock Health Sciences Trust is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, BlackRock Health Sciences Trust’s stock price was USD 37.44. BlackRock Health Sciences Trust’s stock price has changed by -3.21% over the past week, -4.10% over the past month and -4.95% over the last year.
No recent analyst target price found for BlackRock Health Sciences Trust
No recent average analyst rating found for BlackRock Health Sciences Trust
Company Overview BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States. Read Less
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health s...Read More
Frequently Asked Questions About BlackRock Health Sciences Trust (BME) Stock
Stock Target Advisor's fundamental analysis for BlackRock Health Sciences Trust's stock is Slightly Bearish.
BME stock's dividend yield is 8.40%.
Our analysis grades BME stock's dividend yield at D-. This means that BME stock's dividend yield is above 60% of the stocks in the Asset Management sector in the NYE exchange.
Based on this BME may be a average dividend stock for its sector.
Unfortunately we do not have enough data on BME's stock to indicate what its average analyst target is.
BME stock's Price/Earning ratio is 9.53.
Our analysis grades BME stock's Price / Earning ratio at D-. This means that BME stock's Price/Earning ratio is above 39% of the stocks in the Asset Management sector in the NYE exchange.
Based on this BME may be fairly valued for its sector
The last closing price of BME's stock was USD 37.44.
The most recent market capitalization for BME is USD 0.51B.
Unfortunately we do not have enough analyst data on BME's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BlackRock Health Sciences Trust's stock.
As per our most recent records BlackRock Health Sciences Trust has 0 Employees.
BlackRock Health Sciences Trust's registered address is 50 Hudson Yards, New York, NY, United States, 10001.
You can get more information about it from BlackRock Health Sciences Trust's website at https://www.blackrock.com/investing/products/24022.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About BlackRock Health Sciences Trust (BME) Stock
Stock Target Advisor's fundamental analysis for BlackRock Health Sciences Trust's stock is Slightly Bearish.
BME stock's dividend yield is 8.40%.
Our analysis grades BME stock's dividend yield at D-. This means that BME stock's dividend yield is above 60% of the stocks in the Asset Management sector in the NYE exchange.
Based on this BME may be a average dividend stock for its sector.
Unfortunately we do not have enough data on BME's stock to indicate what its average analyst target is.
BME stock's Price/Earning ratio is 9.53.
Our analysis grades BME stock's Price / Earning ratio at D-. This means that BME stock's Price/Earning ratio is above 39% of the stocks in the Asset Management sector in the NYE exchange.
Based on this BME may be fairly valued for its sector
The last closing price of BME's stock was USD 37.44.
The most recent market capitalization for BME is USD 0.51B.
Unfortunately we do not have enough analyst data on BME's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BlackRock Health Sciences Trust's stock.
As per our most recent records BlackRock Health Sciences Trust has 0 Employees.
BlackRock Health Sciences Trust's registered address is 50 Hudson Yards, New York, NY, United States, 10001.
You can get more information about it from BlackRock Health Sciences Trust's website at https://www.blackrock.com/investing/products/24022.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BME !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
